Akagera Medicines is a company headquartered in Rwanda.
Akagera Medicines develops novel and patented liposomal formulations of antibacterial drugs targeting tuberculosis and other infectious diseases, with operations based in Rwanda and laboratories in the US.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.